- Home
- CYD vs KURA Comparison
CYD vs KURA Comparison
Compare CYD & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYD
- KURA
- Stock Information
- Founded
- CYD 1951
- KURA 2014
- Country
- CYD Singapore
- KURA United States
- Employees
- CYD N/A
- KURA N/A
- Industry
- CYD Industrial Machinery/Components
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CYD Industrials
- KURA Health Care
- Exchange
- CYD Nasdaq
- KURA Nasdaq
- Market Cap
- CYD 609.7M
- KURA 592.7M
- IPO Year
- CYD 1994
- KURA N/A
- Fundamental
- Price
- CYD $14.30
- KURA $5.90
- Analyst Decision
- CYD
- KURA Strong Buy
- Analyst Count
- CYD 0
- KURA 10
- Target Price
- CYD N/A
- KURA $25.50
- AVG Volume (30 Days)
- CYD 297.9K
- KURA 1.6M
- Earning Date
- CYD 02-25-2025
- KURA 05-01-2025
- Dividend Yield
- CYD 2.66%
- KURA N/A
- EPS Growth
- CYD 17.49
- KURA N/A
- EPS
- CYD 1.12
- KURA N/A
- Revenue
- CYD $2,621,360,849.00
- KURA $53,883,000.00
- Revenue This Year
- CYD $6.43
- KURA $44.32
- Revenue Next Year
- CYD $11.20
- KURA $173.73
- P/E Ratio
- CYD $12.71
- KURA N/A
- Revenue Growth
- CYD 6.03
- KURA N/A
- 52 Week Low
- CYD $7.95
- KURA $5.41
- 52 Week High
- CYD $26.10
- KURA $23.48
- Technical
- Relative Strength Index (RSI)
- CYD 41.54
- KURA 38.78
- Support Level
- CYD $13.96
- KURA $5.48
- Resistance Level
- CYD $17.00
- KURA $6.11
- Average True Range (ATR)
- CYD 1.34
- KURA 0.39
- MACD
- CYD -0.14
- KURA 0.01
- Stochastic Oscillator
- CYD 29.29
- KURA 31.82
About CYD China Yuchai International Limited
China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International primarily operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.